Robert Alexander Ingram, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 20,000 shares at $1.45 ($29K) on 2019-11-18, disclosed to the SEC on 2019-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |
| CLSD | BUY | 2016-06-07 | $750K | — | Filing → |